Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation

2012 ◽  
Vol 413 (9-10) ◽  
pp. 933-937 ◽  
Author(s):  
Dina Melki ◽  
Suzanne Lind ◽  
Stefan Agewall ◽  
Tomas Jernberg
Keyword(s):  
Chest Pain ◽  
Natriuretic Peptide ◽  
Prognostic Value ◽  
Troponin T ◽  
St Elevation ◽  
Pain Patients ◽  
High Sensitive Troponin

Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations

2011 ◽  
Vol 45 (4) ◽  
pp. 198-204 ◽  
Author(s):  
Dina Melki ◽  
Suzanne Lind ◽  
Stefan Agewall ◽  
Tomas Jernberg
Keyword(s):  
Chest Pain ◽  
Troponin T ◽  
Diagnostic Value ◽  
Pain Patients ◽  
High Sensitive Troponin

scholarly journals Diagnostic value of exercise-induced changes in circulating high sensitive troponin T in stable chest pain patients

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. 956-956
Author(s):  
M. R. Mouridsen ◽  
O. W. Nielsen ◽  
O. D. Pedersen ◽  
C. M. Carlsen ◽  
T. Intzilakis ◽  
...  
Keyword(s):  
Chest Pain ◽  
Troponin T ◽  
Diagnostic Value ◽  
Stable Chest Pain ◽  
Exercise Induced ◽  
Induced Changes ◽  
Pain Patients ◽  
High Sensitive Troponin

Diagnostic value of exercise-induced changes in circulating high sensitive troponin T in stable chest pain patients

Biomarkers ◽  
2013 ◽  
Vol 18 (8) ◽  
pp. 726-733 ◽  
Author(s):  
Mette Rauhe Mouridsen ◽  
Olav Wendelboe Nielsen ◽  
Ole Dyg Pedersen ◽  
Christian Malchau Carlsen ◽  
Theodoros Intzilakis ◽  
...  
Keyword(s):  
Chest Pain ◽  
Troponin T ◽  
Diagnostic Value ◽  
Stable Chest Pain ◽  
Exercise Induced ◽  
Induced Changes ◽  
Pain Patients ◽  
High Sensitive Troponin

Abstract 576: The Prognostic Value of the Long Pentraxin 3 as Compared to B-Type Natriuretic Peptide and High-Sensitive C-Reactive Protein, and their Combination, as a Prognostic Marker of Mortality in Acute Chest Pain Patients

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Trygve Brügger-Andersen ◽  
Volker Pönitz ◽  
Frederic Kontny ◽  
Harry Staines ◽  
Heidi Grundt ◽  
...  
Keyword(s):  
Chest Pain ◽  
Natriuretic Peptide ◽  
Prognostic Marker ◽  
Prognostic Value ◽  
Acute Chest Pain ◽  
Pentraxin 3 ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Edta Plasma ◽  
Pain Patients

Elevated plasma levels of long pentraxin 3 (PTX3), high-sensitive C-reactive protein (hsCRP) and B-type natriuretic peptide (BNP) are found in acute coronary syndromes (ACS). The aim of this study was to assess the prognostic value of PTX3 as compared to BNP and hsCRP, and their combination, as a prognostic marker of mortality in acute chest pain patients. PTX3 was measured in EDTA plasma with a new, high-sensitive ELISA method (PPMX, Tokyo, Japan). BNP was analysed in EDTA plasma using the Microparticle Enzyme Immunoassay (MEIA) Abbott AxSYM®. HsCRP was measured with the use of an immunoturbidimetric assay (Tinaquant® C-reactive protein (latex) high sensitive assay, Roche Diagnostics). The blood samples were taken on admission in 795 patients. The patients were followed for 24 months concerning mortality. For statistical analysis, the study cohort was divided into quartiles (Q1–4) according to PTX3 levels. A multiple logistic regression was fitted which included standard risk measures. At 24 months follow-up, 121 of the 784 patients included in the model had died. The odds ratio for comparing Q4 versus Q1 for PTX3, BNP and hsCRP were 4.34, 3.35 and 0.52 (p=0.001, p=0.024 and p=0.096), respectively, and the combination of PTX3 and BNP showed an incremental prognostic value (figure ). PTX3 is a new independent marker that strongly predicts long-term all-cause mortality in patients with acute chest pain and the combination of this marker with BNP adds substantially to the prognostic value as compared to either marker alone. Figure The number of biomakers greater than the median for % death in 24 months (p<0.001 for comparing the groups)

Sign in / Sign up

Export Citation Format

Share Document